USANA Health Sciences USNA Debt-to-equity

Debt-to-equity at other companies

Nature's Sunshine ProductsNATR

0.1×0.0×

Lifevantage CorporationLFVN

0.3×-0.1×

NuSkin EnterprisesNUS

0.5×+0.1×

NAG

Niagen BioscienceNAGE

0×0.0×

Solesence, Inc.SLSN

0.6×-0.1×

Hims & Hers HealthHIMS

4.2×+4.1×

FAQ

What is USANA Health Sciences's debt-to-equity?

USANA Health Sciences (USNA) reported debt-to-equity of 0× in Q4 2025.

How has USANA Health Sciences's debt-to-equity changed year-over-year?

USANA Health Sciences's debt-to-equity increased by 10.5% year-over-year, from 0× to 0×.

What is the long-term trend for USANA Health Sciences's debt-to-equity?

Over 5 years (2020 to 2025), USANA Health Sciences's debt-to-equity has grown at a 11.6% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.